Natural killer T cell receptor complex (NKTCR)

The Natural killer T cell receptor complex (NKTCR) is a specialized antigen receptor found on Natural Killer T cells, which are a unique lineage of T cells bridging the innate and adaptive immune systems (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2700360/). Unlike conventional T cell receptors that recognize peptide antigens presented by MHC molecules, the NKTCR specifically recognizes lipid and glycolipid antigens presented by the non-polymorphic, MHC class I-like molecule CD1d (https://pubmed.ncbi.nlm.nih.gov/17291283/). The most prominent subset, Type I or invariant NKT (iNKT) cells, utilizes a highly conserved α-chain (Vα24-Jα18 in humans) paired with a limited set of β-chains (https://www.nature.com/articles/nri1528). Upon activation by ligands such as alpha-galactosylceramide (α-GalCer), the NKTCR triggers the rapid and massive release of various cytokines, including interferon-gamma and interleukin-4, which orchestrate downstream immune responses (https://pubmed.ncbi.nlm.nih.gov/21934666/). This makes the NKTCR a significant therapeutic target for cancer immunotherapy, where NKT cell activation can enhance anti-tumor immunity, as well as for treating autoimmune diseases and infections. However, therapeutic application must carefully manage the risk of NKT cell exhaustion and the potential for systemic cytokine-related toxicities (https://www.frontiersin.org/articles/10.3389/fimmu.2018.01356/full).

Other names

iNKT receptorInvariant T cell receptorVα24-Jα18/Vβ11 TCRCD1d-restricted T cell receptorType I NKT receptor

Agonist activation of the receptor complex by glycolipid ligands presented on CD1d, leading to rapid secretion of Th1 and Th2 cytokines and subsequent activation of other immune cells like NK cells and CD8+ T cells.